These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26659909)

  • 1. Correlation of tumor-associated macrophages and NK cells with bladder cancer size and T stage in patients with solitary low-grade urothelial carcinoma.
    Krpina K; Babarović E; Španjol J; Đorđević G; Maurer T; Jonjić N
    Wien Klin Wochenschr; 2016 Apr; 128(7-8):248-52. PubMed ID: 26659909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of tumor-infiltrating lymphocytes with bladder cancer recurrence in patients with solitary low-grade urothelial carcinoma.
    Krpina K; Babarović E; Jonjić N
    Virchows Arch; 2015 Oct; 467(4):443-8. PubMed ID: 26215559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer.
    Ayari C; LaRue H; Hovington H; Caron A; Bergeron A; Têtu B; Fradet V; Fradet Y
    Hum Pathol; 2013 Aug; 44(8):1630-7. PubMed ID: 23574787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
    Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M
    Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal-subtype bladder tumours show a 'hot' immunophenotype.
    Hodgson A; Liu SK; Vesprini D; Xu B; Downes MR
    Histopathology; 2018 Nov; 73(5):748-757. PubMed ID: 29947424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor immune microenvironment in non-muscle-invasive urothelial carcinoma of the bladder.
    Eich ML; Chaux A; Guner G; Taheri D; Mendoza Rodriguez MA; Rodriguez Peña MDC; Baras AS; Hahn NM; Drake C; Sharma R; Bivalacqua TJ; Rezaei K; Netto GJ
    Hum Pathol; 2019 Jul; 89():24-32. PubMed ID: 31026471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
    Ayari C; LaRue H; Hovington H; Decobert M; Harel F; Bergeron A; Têtu B; Lacombe L; Fradet Y
    Eur Urol; 2009 Jun; 55(6):1386-95. PubMed ID: 19193487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High CD4⁺ T cell density is associated with poor prognosis in patients with non-muscle-invasive bladder cancer.
    Zhang Q; Hao C; Cheng G; Wang L; Wang X; Li C; Qiu J; Ding K
    Int J Clin Exp Pathol; 2015; 8(9):11510-6. PubMed ID: 26617883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.
    Wang B; Wu S; Zeng H; Liu Z; Dong W; He W; Chen X; Dong X; Zheng L; Lin T; Huang J
    J Urol; 2015 Aug; 194(2):556-62. PubMed ID: 25752441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder.
    Kluth LA; Xylinas E; Crivelli JJ; Passoni N; Comploj E; Pycha A; Chrystal J; Sun M; Karakiewicz PI; Gontero P; Lotan Y; Chun FK; Fisch M; Scherr DS; Shariat SF
    J Urol; 2013 Aug; 190(2):480-6. PubMed ID: 23376707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic Analysis of Tumor Tissue-Infiltrating Lymphocytes in Tumor Microenvironment of Bladder Cancer and Upper Urinary Tract Carcinoma.
    Kawashima A; Kanazawa T; Jingushi K; Kato T; Ujike T; Nagahara A; Fujita K; Morimoto-Okazawa A; Iwahori K; Uemura M; Imamura R; Wada H; Nonomura N
    Clin Genitourin Cancer; 2019 Apr; 17(2):114-124. PubMed ID: 30555025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between the recurrence of solitary non-muscle invasive bladder cancer and tumor infiltrating lymphocytes.
    Krpina K; Babarović E; Dorđević G; Fuckar Z; Jonjić N
    Croat Med J; 2012 Dec; 53(6):598-604. PubMed ID: 23275325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High CD204+ tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder.
    Wang B; Liu H; Dong X; Wu S; Zeng H; Liu Z; Wan D; Dong W; He W; Chen X; Zheng L; Huang J; Lin T
    Oncotarget; 2015 Aug; 6(24):20204-14. PubMed ID: 26001293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.
    Yutkin V; Pode D; Pikarsky E; Mandelboim O
    J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder.
    Carballido J; Alvarez-Mon M; Solovera OJ; Menéndez-Ondina L; Durántez A
    J Urol; 1990 Jan; 143(1):29-33. PubMed ID: 2294256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human urothelial bladder cancer generates a clonal immune response: The results of T-cell receptor sequencing.
    Sankin A; Chand D; Schoenberg M; Zang X
    Urol Oncol; 2019 Nov; 37(11):810.e1-810.e5. PubMed ID: 31103336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
    Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
    Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of uroplakin III expression in recurrence of solitary muscle non-invasive bladder cancer.
    Tadin T; Krpina K; Štifter S; Babarović E; Jonjić N
    Pathol Res Pract; 2014 May; 210(5):279-84. PubMed ID: 24553301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of Concomitant Non-muscle-invasive Bladder Cancer in Chinese Patients with Upper Tract Urothelial Carcinoma: Risk Factors, Characteristics, and Predictive Value.
    Fang D; Zhang L; Li X; Yu W; Singla N; Zhao G; Xiong G; Song Y; He Q; He Z; Zhou L
    Ann Surg Oncol; 2015 Aug; 22(8):2789-98. PubMed ID: 25564161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficiency of the EORTC scoring system for the prediction of recurrence and progression of non-muscle-invasive bladder cancer treated by bacillus Calmette-Guerin immunotherapy.
    Ajili F; Darouiche A; Chebil M; Boubaker S
    Ultrastruct Pathol; 2013 Aug; 37(4):249-53. PubMed ID: 23899093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.